Electromedical Technologies, Inc.
OTC: EMED0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Matthew N. Wolfson
- Employees
- 6
- Headquarters
- Scottsdale, United States
- IPO year
- 2021
- Market cap
- $85.5K
- Website
- https://www.electromedtech.com
Loading EMED…
Loading profile data…Frequently asked questions about EMED
What does Electromedical Technologies, Inc. (EMED) do?
Electromedical Technologies, Inc. operates within the U.S. market, specializing in the creation and distribution of bioelectronic medical devices specifically designed for pain management. The company's primary product is WellnessPro Plus, a prescription-based bioelectronic therapy tool utilized by both individual users and healthcare profession...
Where does EMED trade?
Electromedical Technologies, Inc. (EMED) trades on the Other OTC.
What sector is EMED in?
Electromedical Technologies, Inc. (EMED) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Electromedical Technologies, Inc.?
Matthew N. Wolfson is the chief executive officer of Electromedical Technologies, Inc. (EMED).
Where is Electromedical Technologies, Inc. headquartered?
Electromedical Technologies, Inc. is headquartered in United States.
Does EMED pay a dividend?
Electromedical Technologies, Inc. (EMED) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EMED go public?
Electromedical Technologies, Inc. (EMED) completed its initial public offering in 2021.